Asian shares on firm footing as vaccine trials resume

    0
    122
    Asian shares on firm footing as vaccine trials resume

    By Swati Pandey
    SYDNEY (Reuters) – Asian shares firmed on Monday on renewed hopes for a coronavirus vaccine after AstraZeneca (NYSE:AZN) resumed its phase-3 trial though sentiment was still cautious…
    Read More

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here